Immunization and multiple sclerosis: Clinical and immunological implications

International MS Journal

Volumn 7, Issue 3, 2000, Pages 78-87

  Flachenecker, P ^a   Moriabadi, N ^a   Niewiesk, S ^a   Rieckmann, P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CHICKENPOX VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; MUMPS VACCINE; POLIOMYELITIS VACCINE; RUBELLA VACCINE; SMALLPOX VACCINE; TYPHUS VACCINE; VACCINE; YELLOW FEVER VACCINE;

CORRELATION FUNCTION; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; INFECTION PREVENTION; MULTIPLE SCLEROSIS; PRACTICE GUIDELINE; REVIEW; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0034466838     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Neurological complications of immunization
2. Viruses and multiple sclerosis
3. Concepts of viral pathogenesis of multiple sclerosis
4. Is there a case for a virus aetiology in multiple sclerosis?
5. Viral particles induce Ia antigen expression on astrocytes
6. Immunopathogenesis of multiple sclerosis: The role of T cells
7. Impfkomplikationen des ZNS
8. Clinical viral infections and multiple sclerosis
9. Influence of infection on exacerbations of multiple sclerosis
10. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis
11. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis
12. Aktive schutzimpfungen bei multipler sklerose
13. Vaccination of patients with encephalomyelitis disseminata
14. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine
15. Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis
16. A shadow falls on hepatitis B vaccination effort
17. Expanded programme on immunization
18. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination
19. Central nervous system demyelination after immunisation with recombinant hepatitis B vaccine
20. Encephalitis after hepatitis B vaccination. Recurrent disseminated encephalitis or MS?
21. No increase in demyelinating diseases after hepatitis B vaccination
22. Scare of multiple sclerosis from hepatitis B vaccine 'quite unfounded'
23. No evidence that hepatitis B vaccine causes multiple sclerosis
24. School-based hepatitis B vaccination programme and adolescent multiple sclerosis
25. Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989-1998) (in French)
26. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
27. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis
28. Infection and immunization in multiple sclerosis
29. Immune status of patients with multiple sclerosis. Analysis of primary and established immune responses in 24 patients
30. Influenza vaccination in patients with multiple sclerosis
31. Swine flu vaccine and multiple sclerosis
32. Swine influenza virus vaccination in patients with multiple sclerosis
33. Swine-influenza vaccination in multiple sclerosis
34. Swine influenza vaccination in patients with multiple sclerosis
35. Serial magnetic resonance imaging studies with paramagnetic contrast medium: Assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination
36. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination
37. Influenza virus vaccination of patients with multiple sclerosis
38. Vaccination in multiple sclerosis - T-cell responses in influenza vaccine recipients
39. Escalating immunotherapy of multiple sclerosis (Austrian-German-Swiss Multiple Sclerosis Therapy Consensus Group)
40. Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: Results from a pilot study
41. The effect of influenza vaccination on human immunodeficiency virus type 1 load: A randomized, double-blind, placebo-controlled study
42. Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial
43. Influenza vaccination in kidney transplant recipients: Cellular and humoral immune responses
44. Effective immunization against influenza in pediatric renal transplant recipients
45. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine
46. Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids
47. Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon